Fractional Chief AI Officer: A First 90-Day Operating Plan for Healthcare Leaders

Author: Eunoia Consulting Co. | Published: October 22, 2026

A practical first-90-day operating plan for a healthcare Fractional Chief AI Officer: clarify decision rights, inventory AI-enabled workflows, prioritise evidence, run accountable pilots and establish an operating rhythm for governance, change and executive oversight.

Healthcare leaders do not need a large AI programme before they need clear ownership. As AI-enabled tools enter patient access, documentation, revenue operations, analytics, clinical support and vendor workflows, organisations need a practical way to decide what is in scope, what evidence is sufficient, who can approve a change and how concerns reach the right people.

A Fractional Chief AI Officer can help create that operating discipline without presenting AI governance as a single-person function or a catalogue of policies. The role is most useful when it connects clinical, business operations, technology, data, privacy, security and vendor decisions into a clear working rhythm for the organisation’s actual priorities.

This article describes a practical first 90-day plan. It is an operating model, not a universal job description, regulatory standard or promise of outcomes. Each healthcare organisation must determine the responsibilities, authority and specialist review required for its own setting.

Clarify the role before the first meeting

A fractional executive role should begin with a written mandate. Without one, the role can become a collection point for every AI question without the authority, data or operating relationships needed to answer any of them.

Start with five decisions:

• What business, care-delivery or operating outcomes is leadership trying to improve?
• Which existing and proposed AI-enabled workflows are in scope?
• What decisions can the role make, recommend, convene or escalate?
• Which functions retain accountability for clinical, privacy, security, legal, financial and operational decisions?
• What evidence and reporting cadence will leadership expect?

The aim is not to make one executive personally responsible for every AI outcome. It is to establish a visible operating system. The role should connect the people who own the work, clarify decision rights and make unresolved dependencies visible before AI use expands by convenience.

At the federal level, the U.S. Department of Health and Human Services describes its Chief AI Officer as leading enterprise-wide strategy for responsible adoption, governance and oversight of AI technologies. A healthcare provider or practice does not need to copy that federal structure. It is still a useful illustration that AI leadership needs to coordinate strategy, governance, oversight and stakeholders rather than focus on tool selection alone. Read HHS’s AI leadership overview.

Days 1–30: create visibility and a decision baseline

The first month should produce a clear view of the current state. Begin with a concise inventory of AI-enabled systems, pilots, vendor features and proposed use cases. Include tools that teams may not call “AI,” such as automated drafting, prioritisation, classification, predictive scores, conversation intelligence, analytics features or embedded vendor assistants.

For each item, capture the following:

• system or vendor and current feature or configuration;
• intended use, users, workflow and output;
• data inputs, interfaces and source systems;
• human-review, override and escalation points;
• current owner and decision maker;
• available evidence, documents and known limitations;
• contract, implementation or change dependencies; and
• next review date or event trigger.

Do not turn the first inventory into a maturity score too early. The purpose is to expose what the organisation does and does not know. A simple, accurate inventory is more useful than a polished deck that treats every system as equally understood.

Next, identify a small set of priority workflows. A valuable prioritisation conversation separates business importance from risk and readiness. A high-value use case with unclear data ownership, no human review or no implementation owner may require a different first step than a lower-risk administrative use with a strong workflow baseline.

The National Institute of Standards and Technology describes its AI Risk Management Framework as voluntary guidance to help organisations incorporate trustworthiness considerations into AI design, development, use and evaluation. Its Govern, Map, Measure and Manage functions can help structure a first-month assessment without treating a framework as a certification. Review the NIST AI RMF.

Days 31–60: establish the decision path and pilot discipline

Once leadership can see the portfolio, the next task is to create a repeatable way to make decisions. The practical output is a short decision packet that teams use for proposed AI-enabled workflows, material changes and pilots.

A useful decision packet answers:

• What is the intended use and what is expressly out of scope?
• What workflow, users, data and interfaces are involved?
• What does the output influence, and what is the human role?
• What evidence has been reviewed, and what does it not demonstrate?
• What could go wrong in this local workflow?
• What conditions must be satisfied before expansion or routine use?
• Who owns each action, and when will the decision be revisited?

This structure helps a team move beyond one-word approvals. A decision can be to proceed, proceed with conditions, defer for further evidence or decline the proposed use. The option to proceed with conditions is especially useful because it allows progress without hiding unresolved work.

At this stage, define a narrow pilot method. A pilot should have a stated hypothesis, baseline, scope, test scenarios, human-review process, success measures, known limitations, exception route and stop conditions. It is not enough to invite users to “try the tool” and collect impressions after the fact.

For a practical local testing framework, see Eunoia’s guide to healthcare AI local validation. It focuses on the evidence and workflow tests needed before an organisation becomes operationally dependent on a new AI-enabled capability.

Days 61–90: make governance operational

The third month turns the assessment and pilot method into a recurring operating rhythm. That does not require building a large committee immediately. It does require reliable routes for decisions, changes, exceptions and reporting.

A practical operating rhythm can include:

• a recurring portfolio review for new proposals, material changes and open conditions;
• a short executive update focused on decisions needed, risks, progress and blocked dependencies;
• a controlled evidence register for vendor claims, documentation, versions and local relevance;
• a defined route for users to report exceptions, unclear outputs, workflow concerns and system changes; and
• a quarterly review of prioritised use cases, realised learning and next steps.

Define the minimum participants for each decision rather than insisting that every stakeholder attends every review. A patient-facing clinical decision support feature may need clinical, quality, privacy, security, technology and operational participation. A low-risk internal drafting pilot may need a smaller group, provided the use, data and accountability are clear.

The relevant question is not “Who should be on the AI committee?” It is “Which accountable perspectives must be present for this decision?”

Create an evidence and change-control habit

The work of a fractional AI leader extends beyond choosing a tool. It includes helping an organisation retain the reasoning behind a decision as the vendor, data, workflow and system change.

For each approved or conditional use, retain the version, intended use, evidence reviewed, conditions, accountable owners, training needs, monitoring plan and next review trigger. If a vendor release changes the model, data flow, interface, user group or workflow behaviour, the organisation should have a clear route to decide whether the original conditions still hold.

This habit makes the organisation more resilient. It reduces reliance on memory, helps leadership distinguish routine updates from material changes and provides a shared reference when a concern arises.

Eunoia’s healthcare AI procurement evidence register is a useful companion for converting vendor representations into decision-ready evidence. The AI governance committee charter guide outlines a lightweight way to establish decision rights, meetings and escalation routes.

Measure the operating system, not only the tools

A 90-day plan should not promise financial, clinical or compliance outcomes that have not been demonstrated. Instead, track whether the organisation is building the conditions to make better decisions.

Possible early measures include:

• the proportion of priority AI-enabled workflows with a clear owner and intended-use statement;
• the number of open conditions and overdue actions;
• whether pilots have a baseline, test plan and documented decision;
• the time required to route a material change or exception to accountable review;
• completion of role-appropriate training; and
• whether teams can identify a fallback or pause procedure for critical workflows.

These measures are not universal benchmarks. They are signals of whether the operating model is becoming usable. The right measures depend on the organisation’s priorities and maturity.

Avoid the common first-90-day traps

Three traps recur in early AI programmes. The first is treating a tool inventory as governance. An inventory is necessary, but it does not assign decision rights, evidence requirements or review triggers. The second is treating a policy as implementation. Teams need workflows, owner actions, training, templates and escalation routes. The third is trying to solve the entire portfolio at once. A focused first 90 days should create a durable method for the next decisions.

A fractional leadership model is effective when it leaves the organisation with clearer priorities, practical decision materials, named owners and a repeatable process-not dependence on a single advisor.

Build an AI leadership rhythm that fits your organisation

Eunoia Consulting Co. helps healthcare organisations create practical AI operating models that connect governance, procurement, implementation, workflow design and accountable oversight. Explore Fractional Chief AI Officer support, review AI governance advisory or contact our team to discuss a focused first-90-day programme for a defined healthcare portfolio.

Sources

• U.S. Department of Health and Human Services: Harnessing AI to Power the HHS Mission
• National Institute of Standards and Technology: AI Risk Management Framework